Skip to main content
Screener/Healthcare/Biotechnology

LIMN — Liminatus Pharma, Inc. Class A Common Stock

NASDAQ
$0.28+0.09 (+49.41%)
Penny StockUnder $1Under $5Healthcare
$0.16
$33.66
$0.26
$0.36
EPS (TTM)$-2.91
P/E Ratio-0.49
Dividend Yield—
Market Cap$6.3M
Volume288.98M
Prev Close$0.19
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q4 '25$0-$8.2M$-0.30——
Q3 '25$0-$1.8M$-0.07——
Q2 '25$0$113K$0.00——
Q1 '25$0-$255$-2.55——
Q4 '24$0-$868K$-0.12——
Q3 '24$0-$643K$-0.09——
Q2 '24$0-$535K$-0.07——
Q1 '24$0-$1.8M$-0.23——
Get Your Daily Market Recap